ArticleInternational journal of retina and vitreous2015

A Value-Based Medicine cost-utility analysis of genetic testing for neovascular macular degeneration.

Gary C Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.